BMO Capital lowered the firm’s price target on ManpowerGroup (MAN) to $48 from $54 and keeps a Market Perform rating on the shares after its Q1 ...

Upon completion of the Transaction, the Parties expect that the board of directors of the Resulting Issuer will consist of the following four (4) directors, of whom three (3) will be independent. John ...

Investing.com -- BMO Capital Markets downgraded Novo Nordisk (NYSE:NVO) to “Market Perform” from “Outperform” and cut its price target to $64, saying the Danish drugmaker’s early lead in ...

BMO Capital Markets upgraded shares of 70489 (PAA.TO) (TSE:PAA – Free Report) (NASDAQ:PAAS) to a hold rating in a research report released on Tuesday morning,Zacks.com reports. Separately ...

Shares of ERO opened at $10.93 on Wednesday. Ero Copper has a fifty-two week low of $9.30 and a fifty-two week high of $24.34. The company’s fifty day moving average is $12.28 and its two ...

Another factor in the market clash is reliable supply. Even though the FDA has removed Novo's semaglutide from its shortage list, the BMO analysts said the company's supply issues "continue to ...

Fintel reports that on April 17, 2025, BMO Capital upgraded their outlook for Trex (BMV:TREX1) from Market Perform to Outperform. There are 1,019 funds or institutions reporting positions in Trex.

BMO Capital raised the firm’s price target on Netflix (NFLX) to $1,200 from $1,175 and keeps an Outperform rating on the shares following the Q1 report. Netflix effectively launched its Ad Suite ...

On a recent call with analysts at BMO Capital Markets, an enigmatic “former director” at the FDA’s Center for Biologics Evaluation and Research (CBER)—who resigned in March—raised ...